Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron M Gruver

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pathology|March 6, 2010
Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinomaAaron M Gruver, Ziad Peerwani, Raymond R Tubbs
Archives of Pathology & Laboratory Medicine|April 30, 2011
Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classificationAaron M Gruver, Bryce P Portier, Raymond R Tubbs
Proteomics|August 7, 2009
The interaction profile of homologous recombination repair proteins RAD51C, RAD51D and XRCC2 as determined by proteomic analysisChanganamkandath Rajesh, Aaron M Gruver, Venkatesha Basrur, et al.
The American Journal of Surgical Pathology|September 18, 2012
Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomasAaron M Gruver, Michael A Huba, Ahmet Dogan, et al.
Cancer Research|March 23, 2005
Extensive chromosomal instability in Rad51d-deficient mouse cellsPhillip G Smiraldo, Aaron M Gruver, Joshua C Osborn, et al.
BMC Molecular Biology|March 31, 2009
Functional characterization and identification of mouse Rad51d splice variantsAaron M Gruver, Brian D Yard, Campbell McInnes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 26, 2022
Two Instrument Comparison of Reagents From a US FDA-Approved Assay for the Assessment of Ki-67 in High-Risk Early Breast CancerMiglena Komforti, Erinn Downs-Kelly, Francisco Sapunar, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 7, 2010
Novel ophthalmic pathology in an autopsy case of autosomal dominant retinal vasculopathy with cerebral leukodystrophyAaron M Gruver, Lynn Schoenfield, Joshua F Coleman, et al.
Breast Cancer Research : BCR|November 2, 2022
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancerMichael Crager, Sameera R Wijayawardana, Aaron M Gruver, et al.
New Biotechnology|April 17, 2012
From morphologic to molecular: established and emerging molecular diagnostics for breast carcinomaBryce P Portier, Aaron M Gruver, Michael A Huba, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pathology|March 6, 2010
Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinomaAaron M Gruver, Ziad Peerwani, Raymond R Tubbs
Archives of Pathology & Laboratory Medicine|April 30, 2011
Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classificationAaron M Gruver, Bryce P Portier, Raymond R Tubbs
Proteomics|August 7, 2009
The interaction profile of homologous recombination repair proteins RAD51C, RAD51D and XRCC2 as determined by proteomic analysisChanganamkandath Rajesh, Aaron M Gruver, Venkatesha Basrur, et al.
The American Journal of Surgical Pathology|September 18, 2012
Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomasAaron M Gruver, Michael A Huba, Ahmet Dogan, et al.
Cancer Research|March 23, 2005
Extensive chromosomal instability in Rad51d-deficient mouse cellsPhillip G Smiraldo, Aaron M Gruver, Joshua C Osborn, et al.
BMC Molecular Biology|March 31, 2009
Functional characterization and identification of mouse Rad51d splice variantsAaron M Gruver, Brian D Yard, Campbell McInnes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 26, 2022
Two Instrument Comparison of Reagents From a US FDA-Approved Assay for the Assessment of Ki-67 in High-Risk Early Breast CancerMiglena Komforti, Erinn Downs-Kelly, Francisco Sapunar, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 7, 2010
Novel ophthalmic pathology in an autopsy case of autosomal dominant retinal vasculopathy with cerebral leukodystrophyAaron M Gruver, Lynn Schoenfield, Joshua F Coleman, et al.
Breast Cancer Research : BCR|November 2, 2022
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancerMichael Crager, Sameera R Wijayawardana, Aaron M Gruver, et al.
New Biotechnology|April 17, 2012
From morphologic to molecular: established and emerging molecular diagnostics for breast carcinomaBryce P Portier, Aaron M Gruver, Michael A Huba, et al.
Pageof 4